Johnson Chemical Pharmaceutical Works Co., Ltd. (4747.TWO)

TWD 70.7

(-3.42%)

Revenue Summary of Johnson Chemical Pharmaceutical Works Co., Ltd.

  • Johnson Chemical Pharmaceutical Works Co., Ltd.'s latest annual revenue in 2023 was 606.71 Million TWD , up 22.65% from previous year.
  • Johnson Chemical Pharmaceutical Works Co., Ltd.'s latest quarterly revenue in 2024 Q2 was 150.41 Million TWD , down -7.83% from previous quarter.
  • Johnson Chemical Pharmaceutical Works Co., Ltd. reported a annual revenue of 494.67 Million TWD in annual revenue 2022, up 20.21% from previous year.
  • Johnson Chemical Pharmaceutical Works Co., Ltd. reported a annual revenue of 411.49 Million TWD in annual revenue 2021, down -2.95% from previous year.
  • Johnson Chemical Pharmaceutical Works Co., Ltd. reported a quarterly revenue of 163.17 Million TWD for 2024 Q1, up 5.46% from previous quarter.
  • Johnson Chemical Pharmaceutical Works Co., Ltd. reported a quarterly revenue of 154.73 Million TWD for 2023 Q4, up 4.54% from previous quarter.

Annual Revenue Chart of Johnson Chemical Pharmaceutical Works Co., Ltd. (2023 - 2019)

Historical Annual Revenue of Johnson Chemical Pharmaceutical Works Co., Ltd. (2023 - 2019)

Year Revenue Revenue Growth
2023 606.71 Million TWD 22.65%
2022 494.67 Million TWD 20.21%
2021 411.49 Million TWD -2.95%
2020 424.01 Million TWD -0.31%
2019 425.33 Million TWD 0.0%

Peer Revenue Comparison of Johnson Chemical Pharmaceutical Works Co., Ltd.

Name Revenue Revenue Difference
Allied Biotech Corporation 720.43 Million TWD 15.785%
GeneFerm Biotechnology Co., Ltd. 793.77 Million TWD 23.566%
Easywell Biomedicals, Inc. 271.62 Million TWD -123.361%
TTY Biopharm Company Limited 5.5 Billion TWD 88.98%
Synmosa Biopharma Corporation 5.14 Billion TWD 88.197%
Orient EuroPharma Co., Ltd. 4.59 Billion TWD 86.787%
Center Laboratories, Inc. 1.39 Billion TWD 56.477%
Tien Liang BioTech Co., Ltd. 459.99 Million TWD -31.896%
Orient Pharma Co., Ltd. 889.91 Million TWD 31.823%
InnoPharmax Inc. 46.07 Million TWD -1216.847%
Excelsior Biopharma Inc. 771.56 Million TWD 21.366%
DV Biomed Co., Ltd. 1.53 Billion TWD 60.561%
Foresee Pharmaceuticals Co., Ltd. 195.03 Million TWD -211.073%
Handa Pharmaceuticals, Inc. 1.1 Billion TWD 45.16%
UniPharma Co., Ltd. 103.22 Million TWD -487.773%
Anxo Pharmaceutical Co., Ltd. 939.94 Million TWD 35.452%
Alar Pharmaceuticals Inc. 469.27 Million TWD -29.288%
Winston Medical Supply Co., Ltd. 709.07 Million TWD 14.436%
Mercury Biopharmaceutical Corporation 1.03 Million TWD -58632.914%
Bioray Biotech Co., Ltd 191.83 Million TWD -216.275%
TSH Biopharm Corporation Limited 810.91 Million TWD 25.182%